Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Goldman Sachs Downgrades Evercore to Neutral, Lowers Price Target to $141

Goldman Sachs analyst Richard Ramsden downgrades Evercore (NYSE:EVR) from Buy to Neutral and lowers the price target from $176 to $141.
byBenzinga Newsdesk
January 6, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Goldman Sachs analyst Richard Ramsden downgrades Evercore (NYSE:EVR) from Buy to Neutral and lowers the price target from $176 to $141.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AC Immune CEO Said Number of Families Affected by Alzheimer’s Could Nearly Triple by 2050 in Interview With German Business Magazine Wirtschaftswoche on Sunday

By Charles Gross
Today, 10:17 PM
https://www.reuters.com/business/healthcare-pharmaceuticals/ac-immune-says-number-families-affected-by-alzheimers-could-nearly-triple-by-2021-11-07/ https://www.wiwo.de/unternehmen/industrie/ac-immune-biontech-investoren-steigen-beim-alzheimer-spezialisten-ein/27772700.html

ACIU